Quick Answer
Envoy Medical, Inc. reported Cash And Cash Equivalents At Carrying Value of $4.22 million for the year ending 2023.
- Envoy Medical, Inc. showed an increase of +2,204.9% in Cash And Cash Equivalents At Carrying Value from 2022 to 2023.
- This data is from Envoy Medical, Inc.'s annual report (Form 10-K), filed with the SEC on April 1, 2024.
- XBRL data for this metric is available from 2020 to 2023 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $2.15 million | Q2 2021: $1.74 million | Q3 2021: $1.03 million | Q1 2022: $127.1 thousand | Q2 2022: $476.9 thousand | Q3 2022: $302.0 thousand | Q1 2023: $104.0 thousand | Q2 2023: $132.8 thousand | Q3 2023: $7.44 million.
- Over the full 4 years of available data (2020 to 2023), Envoy Medical, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 16,772.0%.
- Historical annual values: Fiscal year 2023: $4.22 million | Fiscal year 2022: $183.0 thousand | Fiscal year 2021: $149.8 thousand | Fiscal year 2020: $25.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: